JPRN-jRCTs031200307招募中2 期
Efficacy and safety of epicutaneous immunotherapy for severe hen's egg allergy
Iwai Fumiko0 个研究点目标入组 63 人开始时间: 2021年1月18日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 63
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 4age old 至 <= 15age old（—）
- 性别
- All
入选标准
- •1 Immediate-type of hen's egg allergy
- •2 specific IgE to egg white at 3.5 UA/mL or more
- •3 Participants who have threshold of egg protein cumulative dose of 150mg or less
排除标准
- •1 Participants with severe symptoms in oral food challenge for hen's egg allergy
- •2 Participants who have had only gastrointestinal symptoms as allergic symptoms
- •3 Poorly controlled participants with bronchial asthma and/or atopic dermatitis
- •4 Participants receiving immunotherapy for other food allergens during this trial
研究者
相似试验
已完成
2 期
Efficacy and safety of epicutaneous immunotherapy for severe egg allergyFood allergyJPRN-UMIN000022348ational Hospital Organization Mie National Hospital40
已完成
2 期
Efficacy and safety of epicutaneous immunotherapy for severe milk allergyFood allergyJPRN-UMIN000024564ational Hospital Organization Mie National Hospital46
已完成
2 期
Efficacy and safety of epicutaneous immunotherapy for severe egg allergy; Long term trialFood allergyJPRN-UMIN000025381ational Hospital Organization Mie National Hospital20
已完成
2 期
Efficacy and safety of epicutaneous immunotherapy for severe milk allergy; Long term trialFood allergyJPRN-UMIN000027459ational Hospital Organization Mie National Hospital46
尚未招募
不适用
Efficacy of the epicutaneous immunotherapy for food allergy -Selection of skin sticking device and allergenmilk allergyJPRN-UMIN000037562Tokai University Hachioji Hospital40